Prabhudas Lilladher has issued an Accumulate rating on Aurobindo Pharma Ltd. (ARBP), setting a target price of Rs 1,475.

Sharekhan has reiterated its Buy rating on Exide Industries Ltd. with an upgraded target price of Rs 534.

Prabhudas Lilladher maintains a Buy rating on Jupiter Life Line Hospitals (JLHL) with an upgraded target price of Rs 1,660.

Through the years, the Indibet official website has established itself as a cornerstone in India for online betting, combining dependability with innovation.

Prabhudas Lilladher has reaffirmed its Buy rating on Fortis Healthcare (FORH), setting a revised target price of Rs 710, indicating a potential upside from the current market price of Rs 621.

Prabhudas Lilladher has reaffirmed its Buy rating for Lupin (LPC), raising the target price to Rs 2,420. This revision underscores confidence in Lupin’s strong performance in the U.S.